DÄ internationalArchive11/2010Patients Are Completely Unaware

Correspondence

Patients Are Completely Unaware

Dtsch Arztebl Int 2010; 107(11): 195-6. DOI: 10.3238/arztebl.2010.0195c

Stiebler, A

LNSLNS How can the treatment with glucocorticoids be regarded as the gold standard if not a single study thus far has shown efficacy for any treatment of sudden idiopathic sensorineural hearing loss on the evidence base of a phase III study?

The term “gold standard” in itself implies a rating as a first class treatment on the basis of good evidence.

On this background, the attempts of the professional association of ear, nose, and throat physicians to transform the treatment of sudden idiopathic sensorineural hearing loss into an individual health service do seem ambiguous. Obviously, a treatment that is the worldwide “gold standard” but is not covered by the health insurers can easily be sold as an individual health service.

The victims in all this confusion of different opinions and competing interests are the patients, who in their ignorance often make great personal sacrifices in order to afford such individual health services.
DOI: 10.3238/arztebl.2010.0195c

Dr. med. Andreas Stiebler
Am Bach 2
23972 Lübow, Germany
andreas.stiebler@web.de
1.
Suckfüll M: Perspectives on the pathophysiology and treatment of sudden idiopathic sensorineural hearing loss [Hörsturz – Erwägung zur Pathophysiologie und Therapie]. Dtsch Arztebl Int 2009; 106 (41): 669–76. VOLLTEXT
1. Suckfüll M: Perspectives on the pathophysiology and treatment of sudden idiopathic sensorineural hearing loss [Hörsturz – Erwägung zur Pathophysiologie und Therapie]. Dtsch Arztebl Int 2009; 106 (41): 669–76. VOLLTEXT